Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Private Medicare plans must return overpayments, appeals court rules

Published 08/13/2021, 01:29 PM
Updated 08/13/2021, 01:30 PM
© Reuters. FILE PHOTO: The corporate logo of the UnitedHealth Group appears on the side of one of their office buildings in Santa Ana, California, U.S., April 13, 2020. REUTERS/Mike Blake

By Brendan Pierson

(Reuters) - A U.S. appeals court on Friday revived a rule requiring private insurers that administer federally funded Medicare plans to return potentially billions of dollars in overpayments they receive based on incorrect diagnoses.

The unanimous ruling by a panel of the D.C. Circuit Court of Appeals in Washington was a setback for UnitedHealth Group Inc (NYSE:UNH), which had successfully challenged the rule in a lower court.

UnitedHealth did not immediately respond to a request for comment. Nor did the U.S. Department of Health and Human Services, which oversees Medicare, the federal health insurance program for seniors and certain people with disabilities.

The 2014 rule applies to so-called Medicare Advantage insurance plans, which are funded through HHS but administered by private insurers like UnitedHealth.

HHS pays Medicare Advantage plans a base amount per beneficiary, adjusted according to diagnostic codes reflecting each beneficiary's individual risk factors.

Under the rule, if a Medicare Advantage insurer learns that it received a payment based on an unsupported diagnosis, it must return that payment within 60 days.

According to a 2016 federal audit, the government paid out about $16.2 billion that year based on unsupported diagnoses, nearly 10% of the total paid to Medicare Advantage insurers.

In its 2016 lawsuit, UnitedHealth argued that the overpayment rule treated Medicare Advantage differently from traditional Medicare, which pays providers on a fee-for-service basis and does not comprehensively audit claims for overpayments. The insurer said the difference ran afoul of the Medicare law's requirement of "actuarial equivalence" between Medicare Advantage and traditional Medicare.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In 2018, U.S. District Judge Rosemary Collyer in Washington agreed, overturning the rule.

Circuit Judge Cornelia Pillard, however, wrote for the appeals court panel Friday that there was "no basis" to conclude that Congress intended the actuarial equivalence requirement to "thwart" insurers' obligation to return overpayments.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.